1. Home
  2. DOX vs KRYS Comparison

DOX vs KRYS Comparison

Compare DOX & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amdocs Limited

DOX

Amdocs Limited

HOLD

Current Price

$66.41

Market Cap

7.0B

Sector

Technology

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$261.90

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOX
KRYS
Founded
1982
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
7.8B
IPO Year
1998
2017

Fundamental Metrics

Financial Performance
Metric
DOX
KRYS
Price
$66.41
$261.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$92.33
$297.60
AVG Volume (30 Days)
1.0M
217.1K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
3.45%
N/A
EPS Growth
N/A
128.00
EPS
N/A
6.84
Revenue
N/A
$389,130,000.00
Revenue This Year
$4.48
$39.88
Revenue Next Year
$3.76
$34.38
P/E Ratio
$13.65
$38.23
Revenue Growth
N/A
33.94
52 Week Low
$63.33
$123.03
52 Week High
$94.61
$298.30

Technical Indicators

Market Signals
Indicator
DOX
KRYS
Relative Strength Index (RSI) 48.15 53.83
Support Level $66.13 $251.93
Resistance Level $70.61 $263.75
Average True Range (ATR) 1.62 9.28
MACD 0.47 1.91
Stochastic Oscillator 86.70 80.82

Price Performance

Historical Comparison
DOX
KRYS

About DOX Amdocs Limited

Amdocs Ltd is a provider of software and services to communications, entertainment, and media service providers. The Company operates in a single segment and designs, develops, markets, supports, implements, and operates open and modular cloud offerings. Its portfolio includes solutions across digital business systems and legacy business and operational support systems, supporting multiple lines of business such as wireless, broadband, cable, fiber, satellite, and digital services. The Company leverages artificial intelligence to support digital transformation, cloud adoption, and intelligent network automation. Geographically, it derives a majority of its revenue from North America and also operates in Europe and the rest of the world.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: